Regulus Therapeutics Inc. (RGLS)
Data as of , from SEC Form 4 filings.
See up to 3 months of RGLS. The 7-day demo opens the 1M and 3M ranges and puts RGLS on your watchlist.
Start 7-day demoLatest RGLS insider trades
William H. RastetterOther44,264 sh- William H. RastetterDerivative57,292 sh
- William H. RastetterDerivative
About Regulus Therapeutics Inc. (RGLS)
Regulus Therapeutics Inc. files with the SEC under CIK 0001505512 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
RGLS Form 4 activity by transaction type, last 90 days
No Form 4 activity for RGLS in the last 90 days.
RGLS insider transactions (Form 4)
436 Form 4 filings on record, the earliest from Apr 30, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| William H. Rastetter | Other | Common Stock | 44,264 | - | - | |
| William H. Rastetter | Derivative | Common Stock | 57,292 | - | - | |
| William H. Rastetter | Derivative | Stock Option | 4,650 | - | - | |
| William H. Rastetter | Derivative | Stock Option | 2,325 | - | - | |
| William H. Rastetter | Derivative | Stock Option | 4,000 | - | - | |
| William H. Rastetter | Derivative | Stock Option | 9,000 | - | - | |
| William H. Rastetter | Derivative | Stock Option | 30,000 | - | - | |
| William H. Rastetter | Derivative | Stock Option | 15,000 | - | - | |
| William H. Rastetter | Derivative | Stock Option | 30,000 | - | - | |
| William H. Rastetter | Derivative | Stock Option | 60,000 | - | - | |
| Stelios Papadopoulos | Other | Common Stock | 976,253 | - | - | |
| Stelios Papadopoulos | Derivative | Common Stock | 64,635 | - | - | |
| Stelios Papadopoulos | Derivative | Stock Option | 4,650 | - | - | |
| Stelios Papadopoulos | Derivative | Stock Option | 2,325 | - | - | |
| Stelios Papadopoulos | Derivative | Stock Option | 4,000 | - | - | |
| Stelios Papadopoulos | Derivative | Stock Option | 9,000 | - | - | |
| Stelios Papadopoulos | Derivative | Stock Option | 30,000 | - | - | |
| Stelios Papadopoulos | Derivative | Stock Option | 15,000 | - | - | |
| Stelios Papadopoulos | Derivative | Stock Option | 30,000 | - | - | |
| Stelios Papadopoulos | Derivative | Stock Option | 60,000 | - | - | |
| Stelios Papadopoulos | Derivative | Common Stock Purchase Warrant (Right to Buy) | 59,514 | - | - | |
| David Baltimore | Other | Common Stock | 27,377 | - | - | |
| David Baltimore | Derivative | Common Stock | 57,292 | - | - | |
| David Baltimore | Other | Common Stock | 5,208 | - | - | |
| David Baltimore | Derivative | Common Stock | 57,292 | - | - | |
| David Baltimore | Derivative | Stock Option | 4,650 | - | - | |
| David Baltimore | Derivative | Stock Option | 2,325 | - | - | |
| David Baltimore | Derivative | Stock Option | 4,000 | - | - | |
| David Baltimore | Derivative | Stock Option | 9,000 | - | - | |
| David Baltimore | Derivative | Stock Option | 30,000 | - | - | |
| David Baltimore | Derivative | Stock Option | 15,000 | - | - | |
| David Baltimore | Derivative | Stock Option | 30,000 | - | - | |
| David Baltimore | Derivative | Stock Option | 60,000 | - | - | |
| David Baltimore | Derivative | Stock Option | 4,000 | - | - | |
| David Baltimore | Derivative | Stock Option | 9,000 | - | - | |
| David Baltimore | Derivative | Stock Option | 30,000 | - | - | |
| David Baltimore | Derivative | Stock Option | 15,000 | - | - | |
| David Baltimore | Derivative | Stock Option | 30,000 | - | - | |
| David Baltimore | Derivative | Stock Option | 60,000 | - | - | |
| William H. Rastetter | Grant or award | Common Stock | 62,500 | $0.00 | - | |
| Stelios Papadopoulos | Grant or award | Common Stock | 62,500 | $0.00 | - | |
| David Baltimore | Grant or award | Common Stock | 62,500 | $0.00 | - | |
| David Baltimore | Grant or award | Common Stock | 62,500 | $0.00 | - |
RGLS insider trading FAQ
What is the latest insider trade for RGLS?
Regulus Therapeutics Inc. (RGLS) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-06-25. The full record for RGLS runs to 6 Form 4 filings, the earliest from 2025-04-30. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying RGLS stock?
No insider purchases of RGLS were filed in the last 90 days.
How many insiders are selling RGLS stock?
No insider sales of RGLS were filed in the last 90 days.
Where can I see RGLS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects RGLS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
6The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - William H. Rastetter view on EDGAR
- - Stelios Papadopoulos view on EDGAR
- - David Baltimore view on EDGAR
- - William H. Rastetter view on EDGAR
- - Stelios Papadopoulos view on EDGAR
- - David Baltimore view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where RGLS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow RGLS with a 7-day demo
- RGLS on your watchlist
- Every RGLS Form 4 filing on record
- Up to 3 months of RGLS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
